Novartis Asks 4th Circ. To Block $1M Aredia, Zometa Verdict

Law360, New York (June 12, 2012, 3:10 PM EDT) -- Seeking to undo a $1.2 million verdict related to bone drugs Aredia and Zometa, Novartis Pharmaceuticals Corp. told the Fourth Circuit on Friday that a lower court erred when deciding what evidence to allow in a case that’s part of vast multidistrict litigation.

A North Carolina judge awarded the damages two years ago after jurors found the company failed to warn a woman's doctor the medicines could cause a severe jaw disease known as osteonecrosis.

Novartis contends a new trial is warranted because of various alleged...
To view the full article, register now.